Please login to the form below

Not currently logged in
Email:
Password:

cabotegravir

This page shows the latest cabotegravir news and features for those working in and with pharma, biotech and healthcare.

GSK’s says depot HIV injection works over three years

GSK’s says depot HIV injection works over three years

Three-year results from the phase 2b LATTE-2 study of cabotegravir and rilpivirine, given by injection, show that the pair kept HIV levels suppressed in 90% of the eight-week ... The combination of ViiV’s integrase inhibitor cabotegravir with

Latest news

More from news
Approximately 3 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...

Infographics